![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
1. Meballymal
2. Quinalbarbitone
3. Sebar
4. Secobarbital
5. Seconal
6. Seconal Sodium
7. Sodium, Secobarbital
1. Immenoctal
2. Pramil
3. Sebar
4. Synate
5. Evronal Sodium
6. Quinalbarbitone Sodium
7. Barbosec
8. Sodium Seconal
9. Sodium Secobarbital
10. 309-43-3
11. Bipanal
12. Evrronal
13. Imesonal
14. Quinalspan
15. Sedutain
16. Trisomnin
17. Bipinal Sodium
18. Seconal Sodium
19. Meballymal Sodium
20. Seco 8
21. Sodium Quinalbarbitone
22. (rs)-secobarbital Sodium
23. Xbp604f6um
24. 5-allyl-5-(1-methylbutyl)barbituric Acid Sodium Salt
25. 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, Monosodium Salt
26. Nsc-10818
27. 5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1h,3h,5h)-pyrimidinetrione Monosodium Salt
28. Dea No. 2315
29. Sodium 5-allyl-5-(1-methylbutyl)barbiturate
30. Dormatylan
31. Dormona
32. 5-allyl-5-(1-methylbutyl)malonylurea Sodium Salt
33. Barbituric Acid, 5-allyl-5-(1-methylbutyl)-, Sodium Salt
34. Secobarbitone Sodium
35. Einecs 206-218-4
36. Nsc 10818
37. Secobarbital Sodium [jan]
38. Unii-xbp604f6um
39. Propylmethylcarbinylallyl Barbituric Acid Sodium Salt
40. Seconal Sodium (tn)
41. Secobarbital Sodium [usp:inn:ban:jan]
42. Secobarbital Sodium (jan/usp)
43. Chembl1200903
44. Secobarbital Sodium [mi]
45. Secobarbital Sodium [vandf]
46. Secobarbital Sodium [mart.]
47. Secobarbital Sodium [who-dd]
48. Secobarbital Sodium [green Book]
49. Secobarbital Sodium [orange Book]
50. Secobarbital Sodium [usp Impurity]
51. Secobarbital Sodium [usp Monograph]
52. D01310
53. Q27293769
54. Sodium;5-pentan-2-yl-5-prop-2-enylpyrimidin-3-ide-2,4,6-trione
55. 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propen-1-yl)-, Sodium Salt (1:1)
Molecular Weight | 260.26 g/mol |
---|---|
Molecular Formula | C12H17N2NaO3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 260.11368669 g/mol |
Monoisotopic Mass | 260.11368669 g/mol |
Topological Polar Surface Area | 64.2 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 370 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Seconal sodium |
PubMed Health | Secobarbital (By mouth) |
Drug Classes | Sedative |
Drug Label | The barbiturates are nonselective central nervous system (CNS) depressants that are primarily used as sedative hypnotics. In subhypnotic doses, they are also used as anticonvulsants. The barbiturates and their sodium salts are subject to control unde... |
Active Ingredient | Secobarbital sodium |
Dosage Form | Capsule |
Route | Oral |
Strength | 100mg; 50mg |
Market Status | Prescription |
Company | Marathon Pharms |
2 of 2 | |
---|---|
Drug Name | Seconal sodium |
PubMed Health | Secobarbital (By mouth) |
Drug Classes | Sedative |
Drug Label | The barbiturates are nonselective central nervous system (CNS) depressants that are primarily used as sedative hypnotics. In subhypnotic doses, they are also used as anticonvulsants. The barbiturates and their sodium salts are subject to control unde... |
Active Ingredient | Secobarbital sodium |
Dosage Form | Capsule |
Route | Oral |
Strength | 100mg; 50mg |
Market Status | Prescription |
Company | Marathon Pharms |
Adjuvants, Anesthesia
Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)
GABA Modulators
Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)